• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Ackermans & Van Haaren (ENXTBR:ACKB) Following Strong Earnings Looks Undervalued

    Simply Wall St·08/31/2026 03:21:49
    Listen to the news

    Earnings jump puts Ackermans & Van Haaren in focus

    Ackermans & Van Haaren (ENXTBR:ACKB) just reported half year 2026 results that showed broadly stable revenue of €3,030.22 million, while net income reached €339.56 million and basic earnings per share from continuing operations was €10.39.

    The latest earnings announcement has arrived alongside strong price momentum, with Ackermans & Van Haaren’s share price up 8.2% on the day to €279.2 and a 20.0% share price return year to date, while the 3 year total shareholder return of 101.7% points to a powerful longer term compounding effect.

    Compare Ackermans & Van Haaren’s earnings-driven momentum with a hand picked group of companies on the 266 high quality undervalued stocks that also pair strong fundamentals with recent strength.

    Ackermans & Van Haaren has just paired steady revenues with higher earnings and a strong share price run, which paints the picture of a solid business. The next step is clear: Is that strength already fully priced in?

    Most Popular Narrative: 8.2% Undervalued

    Ackermans & Van Haaren’s most followed narrative points to a fair value of €304.14 per share versus the latest close at €279.2. That gap is built on a detailed set of growth and profitability assumptions rather than sentiment alone.

    The strong growth and record results achieved by Delen Private Bank and Bank Van Breda, with net inflows and synergetic collaboration, signal continued future revenue growth from financial services.

    DEME's record turnover and solid free cash flow generation, paired with reduced net financial debt, set the stage for improved net margins and earnings from enhanced operational efficiency and financial flexibility.

    Read the complete narrative. Read the complete narrative.

    Want to see what sits behind that fair value for Ackermans & Van Haaren? The narrative leans on compound revenue growth, firmer margins and a richer earnings multiple. Curious which specific growth rates and profit assumptions matter most here? The full narrative lays out the roadmap, step by step.

    Result: Fair Value of €304.14 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, you still need to watch for two key pressure points. A setback at core units like Delen Private Bank or DEME, or disappointing returns from newer investments, could quickly challenge the bullish Ackermans & Van Haaren narrative.

    Find out about the key risks to this Ackermans & Van Haaren narrative.

    Next Steps

    If the upbeat tone around Ackermans & Van Haaren has you interested, do not wait to review the details yourself and stress test the thesis. To see what investors are optimistic about, start with the 2 key rewards.

    Looking for more investment ideas beyond Ackermans & Van Haaren?

    If you are serious about building a stronger portfolio, do not stop at Ackermans & Van Haaren. Let the Simply Wall St Screener surface fresh ideas that match your goals.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.